Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

60.82 2.76 +4.75%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.34%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100

Bruker Corporation (BRKR) Book value per share

Alert me on Book value per share

Bruker Corporation's book value per share at the end of fiscal 2025 was 16.3×, up 35.1% from 12.1× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 15.1×. Over the past ten years it has ranged from 4.3× (fiscal 2016) to 16.3× (fiscal 2025) — the current reading is the highest in ten years. Bruker Corporation ranks 25th of 149 Medical Devices companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 16.3× 35.10%
FY2024 12.1× 26.61%
FY2023 9.5× 25.75%
FY2022 7.6× 5.75%
FY2021 7.2× 12.79%
FY2020 6.4× 7.49%
FY2019 5.9× 1.98%
FY2018 5.8× 24.89%
FY2017 4.6× 8.04%
FY2016 4.3× (1.45%)

Quarterly newest first

Period Book value per share Change
Sep 2026 15.1× (4.05%)
Jun 2026 15.8× (2.77%)
Mar 2026 16.2× (0.53%)
Dec 2025 16.3× 0.98%
43 more quarters

Against its own ten years

Low 4.3× High 16.3×
Ten-year median 6.4×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on BRKR